AVEO Pharmaceuticals

$8.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+0.72%) Today
+$0.01 (+0.12%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AVEO and other stocks, options, and ETFs commission-free!

About AVEO

AVEO Pharmaceuticals, Inc. Common Stock, also called AVEO Pharmaceuticals, is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. The listed name for AVEO is AVEO Pharmaceuticals, Inc. Common Stock.

CEO
Michael P. Bailey
Employees
19
Headquarters
Boston, Massachusetts
Founded
2001
Market Cap
248.96M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
632.56K
High Today
$8.44
Low Today
$8.05
Open Price
$8.17
Volume
360.52K
52 Week High
$10.71
52 Week Low
$2.23

Collections

AVEO Earnings

-$0.51
-$0.31
-$0.10
$0.10
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 15, After Hours

You May Also Like

DLR-C
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure